tiprankstipranks
bluebird bio (BLUE)
NASDAQ:BLUE
US Market

Bluebird Bio Financial Overview

Bluebird Bio's market cap is currently ―. The company's EPS TTM is $-35.974; its P/E ratio is ―; Bluebird Bio is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $-5.75. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ -4.03M$ -6.48M$ -35.20M$ -559.26M$ 41.70M
Operating Income$ -244.26M$ -287.09M$ -590.91M$ -559.26M$ -814.83M
EBITDA$ -167.13M$ -277.15M$ -545.46M$ -539.90M$ -772.72M
Net Income$ -211.91M$ -266.58M$ -819.38M$ -618.70M$ -789.61M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 619.16M$ 554.90M$ 593.79M$ 1.78B$ 1.73B
Total Debt$ 330.33M$ 281.39M$ 89.58M$ 65.42M$ 190.99M
Net Debt$ 108.53M$ 101.06M$ -209.92M$ -614.81M$ -915.47M
Total Liabilities$ 424.62M$ 358.56M$ 219.52M$ 426.20M$ 442.43M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -244.06M$ -353.00M$ -659.03M$ -492.87M$ -643.38M
Operating Cash Flow$ -235.00M$ -353.00M$ -636.03M$ -463.88M$ -567.13M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Bluebird Bio Earnings and Revenue History

Bluebird Bio Debt to Assets

Bluebird Bio Cash Flow

Bluebird Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis